Regeneron-licensed obesity drug shows positive phase 3 results in China (REGN:NASDAQ) - Seeking Alpha

2026-03-09 - 12:23

Regeneron-licensed obesity drug shows positive phase 3 results in China (REGN:NASDAQ) Seeking Alpha